Company’s pursuit of patents increases product value in markets
around the globe
COPPELL, Texas--(BUSINESS WIRE)--Feb. 11, 2015--
Mannatech,
Incorporated (NASDAQ:MTEX),
the founder of the M5MSM
(Mission 5 MillionSM) social entrepreneurial movement,
the pioneer of nutritional glycobiology and the global innovator of
naturally sourced supplements based on Real
Food Technology® solutions, has been issued its 100th
patent, demonstrating its commitment to delivering and protecting its
unique formulations in major global markets.
Mannatech receiving 100 patents is an exceptional accomplishment for a
company in the nutritional supplement industry. Mannatech, compared to
many of its competitors, invests heavily in a robust research and
development program to create its unique technology and formulations.
With many of its formulations patented in multiple major global markets,
Mannatech can exclude others from exploiting certain Mannatech patents
and provide its customers with high value, quality products that stand
out in the nutritional supplement crowd.
“It is uncommon for a company in this industry to have even one patent,”
said Dr. Rob Sinnott, CEO and Chief Science Officer at Mannatech.
“Mannatech commits a great deal of resources, time and funding into the
patent process in major global markets to ensure our unique technologies
are recognized, validated and protected.”
The company’s 100th patent was issued in Korea for its
PhytoMatrix® product, an all-natural multivitamin and
multimineral dietary supplement formulation.
“This 100-patent milestone shows Mannatech’s concerted effort to keep
its products from becoming mere commodities in the nutritional
supplement market,” said Sinnott. “We closely guard our core technology
and formulations with patents, which makes our products far more
valuable. We believe this approach helps our Associates to build a
successful business in major global markets around the world.”
The Certificate of Grant for Mannatech’s PhytoMatrix formulation in
Korea was received on Nov. 18, 2014, just 11 days after the 99th
company patent was issued for the PhytoMatrix formulation in Japan on
Nov. 7, 2014. The patent will remain in effect for 20 years from the
date of filing. There are now eight patents issued in major global
markets to Mannatech regarding the PhytoMatrix technology. Overall, 100
patents have been issued, granted and validated in major global markets
to the company for the technology pertaining to its Ambrotose®,
Ambrotose AO®, GI-ProBalance®, and PhytoMatrix
product formulations and in the field of biomarker assays.
Mannatech’s unique PhytoMatrix formulation has been on the market since
2006. It is one of the few vitamin and mineral supplements available
that contains minerals from hydroponically grown Indian Mustard plant
and food-sourced vitamins and phytonutrients from fruits and vegetables.
PhytoMatrix is gluten-free and suitable for vegetarian diets.
Mannatech has a thorough, industry-leading quality assurance program
that complies with the U.S. Food and Drug Administration’s current Good
Manufacturing Practices for dietary supplements, which impact all
aspects of product development, manufacturing, evaluation, storage and
distribution. Additionally, many of Mannatech’s products
feature third-party certification through NSF International. NSF
certification assures that a number of Mannatech products, including
PhytoMatrix, have been rigorously tested and comply with requirements
such as accurate labeling and purity standards.
A number of Mannatech’s broad portfolio of patented products has been
validated by research conducted by independent scientists and published
in peer-reviewed scientific journals. Currently, 17 human clinical
trials have been published, 13 of which were double-blind,
placebo-controlled studies - the gold standard for product validation.
Individuals interested in Mannatech’s products can learn more at Mannatech.com.
Those interested in obtaining technical information and reading
published product studies may visit MannatechScience.org.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skin care products that are based on the solid foundation
of nutritional science and development standards. Mannatech is dedicated
to its platform of Social Entrepreneurship based on the foundation of
promoting, aiding and optimizing nutrition where it is needed most
around the world. Mannatech’s proprietary products are available through
independent sales Associates around the globe including the United
States, Canada, South Africa, Australia, New Zealand, Austria, Denmark,
Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan,
Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech
Republic, the Republic of Korea, Mexico, Namibia, Spain and Hong Kong.
For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “intend” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s objectives,
strategies, plans, goals or targets contained herein are also considered
forward-looking statements. Mannatech believes this release should be
read in conjunction with all of its filings with the United States
Securities and Exchange Commission and cautions its readers that these
forward-looking statements are subject to certain events, risks,
uncertainties and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain Associates and
Members, increases in competition, litigation, regulatory changes and
its planned growth into new international markets. Although Mannatech
believes that the expectations, statements and assumptions reflected in
these forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement in
this release, as well as those set forth in its latest Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, and other filings filed
with the United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150211005157/en/
Source: Mannatech, Incorporated
Mannatech, Incorporated
Raquel Mooring, 972-471-1532
rmooring@mannatech.com